Remedium Lifecare Ltd Financials

Remedium Lifecare Ltd Financial Statement

Remedium Lifecare Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2024	Jun 2024	Mar 2024
Revenue	25.90	79.59	1,411.39
Operating Expense	20.62	77.31	1,443.52
Net Profit	1.78	1.64	-53.72
Net Profit Margin	6.87	2.06	-3.81
Earning Per Share	0.04	0.16	-5.33
EBIDTA	5.28	2.28	-32.12
Effective Tax Rate	12.88	27.63	-55.20

Particulars	Sep 2024
Revenue	25.90
Operating Expense	20.62
Net Profit	1.78
Net Profit Margin	6.87
Earning Per Share	0.04
EBIDTA	5.28
Effective Tax Rate	12.88

Remedium Lifecare Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	4,041.71	509.84	504.79
Operating Expenses Annual	4,008.40	502.37	503.09
Operating Profit Annual	54.38	7.47	1.71
Interest Annual	3.87	-0.08	0.11
Depreciation	0.06	0.15	0.07
Net Profit Annual	32.73	5.43	1.08
Tax Annual	17.72	1.97	0.45

Particulars	Mar 2024
Total Revenue Annual	4,041.71
Operating Expenses Annual	4,008.40
Operating Profit Annual	54.38
Interest Annual	3.87
Depreciation	0.06
Net Profit Annual	32.73
Tax Annual	17.72

Remedium Lifecare Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	21.86	1.44	0.81
Cash Flow from Operations	-74.16	20.50	11.28
Cash Flow from Investing	TBA	-0.04	-0.05
Cash Flow from Financing	53.83	-0.04	-10.61
Cash Flow at the End	1.52	21.86	1.44

Particulars	Mar 2024
Cash Flow at the Beginning	21.86
Cash Flow from Operations	-74.16
Cash Flow from Investing	TBA
Cash Flow from Financing	53.83
Cash Flow at the End	1.52

Remedium Lifecare Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	1.37	1.57	0.36
PBIT Margin (%)	1.37	1.54	0.35
PBT Margin (%)	1.08	-1.88	-1.17
Net PROFIT Margin (%)	0.81	1.07	0.21
Return On Networth / Equity (%)	122.77	70.98	24.55
Return On Networth /Employed (%)	99.50	102.61	18.24
Return On Assets (%)	58.95	70.93	11.19
Total Debt / Equity (X)	1.08	TBA	1.19
Asset Turnover Ratio (%)	72.80	66.60	52.31

Particulars	Mar 2024
PBDIT Margin (%)	1.37
PBIT Margin (%)	1.37
PBT Margin (%)	1.08
Net PROFIT Margin (%)	0.81
Return On Networth / Equity (%)	122.77
Return On Networth /Employed (%)	99.50
Return On Assets (%)	58.95
Total Debt / Equity (X)	1.08
Asset Turnover Ratio (%)	72.80

Remedium Lifecare Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	0.05	0.08	0.19
Total Current Assets Annual	1,947.85	1,154.14	223.57
Non Current Assets Annual	0.07	0.09	0.19
Total Shareholders Funds Annual	42.96	10.36	4.94
Total Assets Annual	1,947.92	1,154.22	223.76

Particulars	Mar 2024
Fixed Assets Annual	0.05
Total Current Assets Annual	1,947.85
Non Current Assets Annual	0.07
Total Shareholders Funds Annual	42.96
Total Assets Annual	1,947.92

Remedium Lifecare Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Dec 26, 2024, Remedium Lifecare Ltd has a market capitalization of 1,093.68 Cr. Value Research classifies it as a Small-Cap company.

No, Remedium Lifecare Ltd is not debt-free with a debt-to-equity ratio of 1.34.

In FY 2023 , Remedium Lifecare Ltd recorded a total revenue of approximately 4,041.71 Cr marking a significant milestone in the company's financial performance.

Remedium Lifecare Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 1.6% and 1.0% annually, respectively..

Remedium Lifecare Ltd's current PE ratio is 33.42.

Remedium Lifecare Ltd's ROCE averaged 52.6% from the FY ending March 2022 to 2024, with a median of 54.0%. It peaked at 70.6% in March 2023, reflecting strong capital efficiency over the period..

Remedium Lifecare Ltd's latest EBIT is Rs. 54.32 Cr, surpassing the average EBIT of Rs. 21.09 Cr over the 5 years..